SABS 2.23 ▼ -1.33% Live Trading Data - Stocknear

SAB Biotherapeutics Inc.

NASDAQ: SABS · Real-Time Price · USD
2.23
-0.03 (-1.33%)
At close: Sep 05, 2025, 11:32 AM
-1.33%
Bid 2.23
Market Cap 23.22M
Revenue (ttm) -410
Net Income (ttm) -37.06M
EPS (ttm) -3.99
PE Ratio (ttm) -0.56
Forward PE -1.98
Analyst Buy
Ask 2.27
Volume 107,730
Avg. Volume (20D) 1,432,779
Open 2.23
Previous Close 2.26
Day's Range 2.20 - 2.25
52-Week Range 1.00 - 6.60
Beta 0.55

About SABS

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SABS
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SABS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

SAB Biotherapeutics Inc. is scheduled to release its earnings on Nov 5, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-3.33%
SAB Biotherapeutics shares are trading lower after... Unlock content with Pro Subscription
1 month ago
+5.06%
SAB Biotherapeutics shares are trading higher after the company announced it has raised $175 million via an oversubscribed private placement to fund its Phase 2 SAFEGUARD trial.